NWU20-02-02
|
CLO-Northwestern University
|
A Randomized and Placebo-Controlled Phase II Trial Targeting Dominant-Negative Missense Mutant P53 By Atorvastatin for Reducing the Risk of Longstanding Ulcerative Colitis-Associated Cancer
|
Cancer Prevention and Control CIRB
|
NWU20-04-01
|
CLO-Northwestern University
|
Metformin for Chemoprevention of Lung Cancer in High-Risk Overweight or Obese Individuals
|
Cancer Prevention and Control CIRB
|
NWU2014-04-01
|
CLO-Northwestern University
|
Statin Therapy to Reduce the Risk of Recurrent Pancreatitis
|
Cancer Prevention and Control CIRB
|
NWU2015-06-01
|
CLO-Northwestern University
|
Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention
|
Cancer Prevention and Control CIRB
|
NWU2015-06-02
|
CLO-Northwestern University
|
Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial
|
Cancer Prevention and Control CIRB
|
NWU2015-06-03
|
CLO-Northwestern University
|
Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer
|
Cancer Prevention and Control CIRB
|
NWU2015-06-04
|
CLO-Northwestern University
|
Phase IIB trial of neoadjuvant oral tamoxifen versus transdermal 4-hydroxytamoxifen in women with DCIS of the breast
|
Cancer Prevention and Control CIRB
|
NWU2016-08-02
|
CLO-Northwestern University
|
A Phase I Single-Arm, Multicenter Pilot Study Aimed at Validating Gamma-OHPdG as a Biomarker and Testing the Effects of Polyphenon E® on its Levels in Patients with Cirrhosis
|
Cancer Prevention and Control CIRB
|
NWU2017-09-01
|
CLO-Northwestern University
|
Phase I trial of endoxifen gel versus placebo gel in women undergoing breast surgery
|
Cancer Prevention and Control CIRB
|
NWU21-08-01
|
CLO-Northwestern University
|
Phase II Trial of Oral Iloprost for the Precision Chemoprevention of Lung Cancer
|
Cancer Prevention and Control CIRB
|